Alkermes PLC (NAS:ALKS)
$ 24.15 -0.31 (-1.27%) Market Cap: 4.09 Bil Enterprise Value: 3.71 Bil PE Ratio: 9.55 PB Ratio: 3.26 GF Score: 65/100

Q1 2019 Alkermes Plc Earnings Call Transcript

Apr 25, 2019 / 12:30PM GMT
Release Date Price: $28.18 (-12.78%)
Operator

Greetings, and welcome to the Alkermes plc First Quarter 2019 Financial Results Conference Call. My name is Rob, and I'll be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded.

I'll now turn the call over to Sandy Coombs, Vice President of Investor Relations. Sandy, you may begin.

Sandra Coombs
Alkermes plc - Co-Head of IR

Thanks, Rob. Good morning. Welcome to the Alkermes plc conference call to discuss our financial results and business update for the quarter ended March 31, 2019.

With me today are Jim Frates, our CFO; Craig Hopkinson, our Chief Medical Officer; and Richard Pops, our CEO.

Before we begin, I encourage everyone to go to the Investors section of alkermes.com to find our press release and related financial tables, including a reconciliation of the GAAP to non-GAAP financial measures that we'll discuss today. We believe the non-GAAP financial results in conjunction with the GAAP results are useful in understanding the ongoing economics of our business.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot